Physician profile
Caroline E Clarke
NPI 1104078781
$8,279.17
in general payments reported to CMS, 2019-2025
16 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,542 · 2020: $521 · 2021: $408 · 2022: $1,993 · 2023: $1,208 · 2024: $2,208 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,091 · Travel and Lodging: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,090.66 |
| Travel and Lodging | $724.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $1,551.93 | 2020-2022 | |
| Mentor Worldwide LLC | $1,464.73 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| W. L. Gore & Associates, INC. | $1,362.55 | 2019-2020 | |
| Axogen | $1,098.44 | 2024-2025 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Abbvie INC. | $745.69 | 2023-2025 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Musculoskeletal Transplant Foundation INC. | $721.46 | 2020-2023 | |
| Davol INC. | $304.37 | 2019-2021 | |
| Galderma Laboratories, L.P. | $224.93 | 2024-2025 | Dysport |
| Sientra, INC. | $181.37 | 2022 | |
| Allergan, INC. | $164.50 | 2022 | |
| Depuy Synthes Sales INC. | $141.28 | 2023 | Matrixmandible, Matrixmidface |
| Kerecis Limited | $130.21 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Revance Therapeutics, INC. | $76.74 | 2024 | Daxxify |
| Mckesson Medical-Surgical, INC. | $48.78 | 2019 | |
| Avita Medical Americas, LLC | $38.94 | 2025 | Cohealyx, Recell, Permeaderm |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $23.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Clarke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.